[Self-Management of Anti-Obstructive Therapy for Severe COPD with a Subcutaneous Terbutaline Pump].
BACKGROUND
Patients with chronic obstructive pulmonary disease (COPD) may be difficult to stabilize with standard inhaled and oral medication. In those cases, outpatient care may even be impossible. Alternative therapeutic strategies, like subcutaneous self-application of terbutaline, could help to further improve health status.


METHODS
A 42-year old patient with severe COPD was admitted to the hospital. Despite maximal anti-obstructive therapy he required additional intravenous relief therapy and discharge was not possible. We treated this patient with a subcutaneous terbutaline pump for continuous and demand medication. We could show a significant decrease in additional intravenous medication, and the patient could leave the hospital.


CONCLUSIONS
The use of terbutaline applied by a subcutaneous pump in addition to standard therapy may be helpful in severely ill patients suffering from COPD. This measure increased quality of life and shortened hospital stay.
Grootoonk
Sandra
S
Abteilung für Pneumologie, Allergologie und Schlafmedizin, Berufsgenossenschaftliche Kliniken Bergmannsheil, Klinikum der Ruhr-Universität Bochum, Bochum.
Schultze-Werninghaus
Gerhard
G
Ehren
Marianne
M
De Zeeuw
Justus
J
Duchna
Hans-Werner
HW
Bauer
Torsten Thomas
TT
D000328:Adult; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D006801:Humans; D015918:Infusion Pumps, Implantable; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012646:Self Administration; D013726:Terbutaline / Q000008:administration & dosage*
D001993:Bronchodilator Agents; D013726:Terbutaline